NASDAQ NMS - GLOBAL MARKET · EDSA
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Edesa Biotech Inc

Edesa Biotech Inc

Biotechnology
$4.43
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
EDSA
Edesa Biotech Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

32/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EDSA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EDSA catalysts
About Edesa Biotech Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2010
Employees
17
Country
CA

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.43
Last session
Day high
$4.43
Last session
Day low
$4.43
Last session
Previous close
$4.43
52W high
$18.27
-75.76% from high
52W low
$0.8000
21% of range
Market cap
$42.7M
EPS
$-0.6000
Beta
0.55
Shares out
9.6M
Avg volume
74.5K
VWAP
$4.43
Last session
Price history computed in-house
1W
-21.59%
1M
-15.62%
3M
-54.33%
1Y
+84.58%
YTD
+211.97%
SMA 50 $6.21 · below
SMA 200 $5.13 · below
52W position 21%

EDSA overview

Veridion Score
32
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EDSA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EDSA Form 4 filings
Public disclosures

Congress activity in EDSA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EDSA in the cached public ledger.

Federal contracts

EDSA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EDSA in this window.
Lobbying spend

EDSA lobbying filings, year to date.

Registered lobbying filings matched to Edesa Biotech Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EDSA in this window.
Loading news for EDSA
Analyst ratings
Sovereign unlock shows live analyst consensus for EDSA.
Options
Sovereign unlock shows live options positioning for EDSA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.